Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Leukemia, Myeloid, Date of authorisation: 06/11/2023, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 November 2023 - 11:06

Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Leukemia, Myeloid, Date of authorisation: 06/11/2023, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/vanflyta-0

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters